CANADA PENSION PLAN INVESTMENT BOARD
PensionPosition in NBIX — Neurocrine Biosciences Inc
CIK 1283718
TORONTO ONTARIO, A6
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,769,718
+$2,031,684 QoQ
Shares Held
81,700
-8.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#133
of 768 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANADA PENSION PLAN INVESTMENT BOARD holds $148,102,974 across 23 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
846,095 | $60,800,386 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,556,933 | $52,748,890 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
81,700 | $13,769,718 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,200 | $3,359,346 | |
| 5 | ALKS |
Alkermes plc.
|
48,500 | $2,541,400 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
491,168 | $2,421,458 | |
| 7 | VTRS |
Viatris Inc
|
141,600 | $2,248,608 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
219,200 | $1,736,064 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,769,718 | 81,700 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,738,034 | 89,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,801,044 | 26,800 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $3,934,097 | 31,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,179,789 | 191,499 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,654,650 | 34,100 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,853,176 | 50,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,148,033 | 66,449 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $26,004,678 | 188,549 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,682,984 | 65,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,423,750 | 57,100 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,244,417 | 98,032 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,168,454 | 80,700 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,669,720 | 64,214 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,242,657 | 11,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $331,432 | 3,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $365,625 | 3,900 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,129,250 | 25,000 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $752,230 | 7,848 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $176,838 | 1,839 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,250,900 | 18,450 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,880,298 | 21,725 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||